Gemcitabin-Teva liquid 200 mg / 5 ml, Konzentrat zur Herstellung einer Infusionslösung

7680650050049 CH-65005 Konzentrat
Gemcitabin-Teva liquid 200 mg / 5 ml, Konzentrat zur Herstellung einer Infusionslösung
Gemcitabin-Teva liquid 200 mg / 5 ml, Konzentrat zur Herstellung einer Infusionslösung
Gemcitabin-Teva liquid 200 mg / 5 ml, Konzentrat zur Herstellung einer Infusionslösung
1 / 3
google

Article details

Package size
1
Selling units
1
Measure
Durchstechflasche(n)
Galenic form
Konzentrat
Galenic group
Tinkturen/Desinfektion

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Summary of Product Characteristics
Allemand
20/03/2025
Summary of Product Characteristics
Français
20/03/2025

Detailed composition

Substance Quantity Type Category
(N/A)
200.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance WIZUS
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK

Reimbursement information

Public price
CHF 37.60
Specialties list
Yes
Generic
Yes
SL addition date: 01/12/2014

Authorization holder

Teva Pharma AG

4051 Basel

Authorization information

Swissmedic authorization number
65005
Drug name
Gemcitabin-Teva liquid, Konzentrat zur Herstellung einer Infusionslösung
Galenic form
KOINF
ATC Code
L01BC05
Authorization status
Z
Dispensing category
A
First authorization
08/04/2014
Authorization expiration date
31/12/9999
IT Number
07.16.1.
Domain
Human medicine
Field of application
Zytostatikum

Package details

Description (FR)
GEMCITABIN Teva liquid 200 mg/5ml flac
Description (DE)
GEMCITABIN Teva liquid 200 mg/5ml Durchstf
Market launch
08/04/2014
Narcotic (BTM)
No

Other package sizes (5)

None
None None
GTIN: None
Not in V1
None
None None
GTIN: None
Not in V1
GEMCITABIN Teva liquid 1 g/25ml flac
1 DUR
GTIN: 7680650050056
View
None
None None
GTIN: None
Not in V1
GEMCITABIN Teva liquid 2 g/50ml flac
1 DUR
GTIN: 7680650050063
View